It is not a drug for direct patient use but is studied and manufactured for research and development purposes, including in the creation of cancer therapies. (S)-4-(8-Amino-3-(pyrrolidin-2-yl)imidazo[5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide is mainly known as a chemical intermediate or impurity employed to synthesize certain pharmaceutical drugs, particularly acalabrutinib.
(S)-4-(8-Amino-3-(pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
| API Name | Acalabrutinib |
|---|---|
| CAS No | 1420478-90-5 |
| Molecular Formula | C22H21N7O |
| Molecular Weight | 399.4 g/mol |
| Synonyms | 4-[8-amino-3-[(2S)-pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
It is not a drug for direct patient use but is studied and manufactured for research and development purposes, including in the creation of cancer therapies. (S)-4-(8-Amino-3-(pyrrolidin-2-yl)imidazo[5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide is mainly known as a chemical intermediate or impurity employed to synthesize certain pharmaceutical drugs, particularly acalabrutinib.
The CAS number of (S)-4-(8-Amino-3-(pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide is 1420478-90-5.
The molecular formula of (S)-4-(8-Amino-3-(pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide is C22H21N7O.
The listed molecular weight of (S)-4-(8-Amino-3-(pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide is 399.4 g/mol.
(S)-4-(8-Amino-3-(pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide is listed as being used in connection with the following API: Acalabrutinib.
The listed synonym or IUPAC name for (S)-4-(8-Amino-3-(pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide is 4-[8-amino-3-[(2S)-pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide.